Background: Seroadaptive behaviors among men who have sex with
F
or at least the last 25 years, many men who have sex with men (MSM) have adopted sexual behaviors based on their partners' perceived HIV status to reduce the risk of HIVacquisition or transmission. These "seroadaptive behaviors," such as serosorting (i.e., selecting partners based on HIV status), are associated with a lower risk of HIV than condomless anal intercourse with HIVpositive/unknown-status partners but a higher risk of HIV than consistent condom use. [1] [2] [3] [4] [5] Over the last decade, as part of routine medical care in the Public Health-Seattle & King County (PHSKC) sexually transmitted disease (STD) clinic, we have collected information from MSM on partner HIV status, condom use, and sexual role, and used those data to infer seroadaptive behaviors. However, this approach does not capture information about the intentionality of behaviors or incorporate information about partner preexposure prophylaxis (PrEP) or antiretroviral therapy (ART) use, new factors that may influence sexual decision making among MSM. Similar data collection to ours, which is relatively complex and somewhat time consuming, has not been widely adopted in other clinical settings. As a result, most seroadaptive behavior data have been obtained in the context of research studies that used detailed sexual behavior questionnaires. These assessments, though informative, are often too long to incorporate into a routine clinical care or HIV testing visit or as part of standard HIV/STD partner services interviews. The National HIV Behavioral Surveillance survey has provided national estimates of seroadaptive behaviors, 6 but data from the National HIV Behavioral Surveillance are limited to MSM from large metropolitan statistical areas with a high burden of AIDS. Consequently, we do not have reliable estimates of the prevalence of seroadaptive behaviors or their association with HIV from diverse clinical or population-based samples of MSM.
To address this, we developed a single, seroadaptive behavior question to ascertain which strategies HIV-negative MSM use to reduce their risk of HIV. The goal of this single-question assessment was to develop a standard seroadaptive behaviors measurement tool to be implemented in a variety of settings, which could serve as a screening tool to identify men at highest risk for HIV. There were 2 objectives for this study. First, we compared the agreement of the single question to a full seroadaptive behaviors survey to ascertain the reliability of the single question. Second, using data from the single question, we assessed the prevalence of seroadaptive behaviors and their association with testing newly HIV positive.
MATERIALS AND METHODS

Study Design and Population
We conducted a cross-sectional study of MSM attending the PHSKC STD clinic from February 2013 to June 2015. We have previously described the recruitment and enrollment procedures for this study. 7 Briefly, all patients presenting to the PHSKC STD clinic for a new problem visit are asked to complete a clinical computer-assisted self-interview (clinical CASI) that includes information on sexual behaviors. Men who reported in the clinical CASI that they had at least 1 male sex partner in the past 12 months were eligible. Participants completed a 10-minute research CASI that asked which seroadaptive behaviors they used in the prior 12 months. Men enrolled during the first 6 weeks of recruitment were paid $5 for their participation; this increased to $10 thereafter. Men could participate in the study more than once. Study procedures were reviewed and approved by the University of Washington Institutional Review Board. All men provided informed consent before their participation.
Data Collection and Measures
The HIV status that men self-reported in the routine nonresearch clinical CASI was used to determine which questions men were asked in the research CASI. Men who did not know their HIV status were considered to be HIV negative for this study.
In the research CASI, we asked men if their decision to select partners, use condoms, or adopt a sexual role was based on their partners' HIV status. The preamble to the survey indicated that all questions referred to behaviors adopted by the respondent to reduce his risk of acquiring or transmitting HIV. Questions were stratified by partnership type (main vs casual) and partner HIV status. For example, "In the past 12 months, how often did you top an HIV-positive casual partner instead of bottom him because he was HIV-positive?" This survey, henceforth referred to as the "full battery" of seroadaptive behaviors, has been previously described. 8 The single seroadaptive behavior question was the final question of the research CASI and was asked of HIV-negative respondents only. We asked, "Which of the following best describes what you did in the last 12 months to reduce your risk of getting HIV?" There were 13 response options (including "None of these"), which are delineated in Table 3 . The 2 behaviors related to PrEP or partner ART use were not included as response options until February 2015. This was a "check all that apply" question so men could report engaging in more than one behavior in the past 12 months.
HIV Testing
HIV testing for research participants was performed if clinically indicated. This testing occurred during the participant's clinic visit, which occurred after the participant completed the research survey. We extracted this HIV test result from participants' clinic records to determine which participants tested newly HIV positive. Our clinic recommends both rapid and laboratory HIV testing for MSM. Clinic staff performed rapid tests using the INSTI HIV-1/HIV2 Antibody Test on whole blood (bioLytical Laboratories, Richmond, British Columbia, Canada) and our laboratory tested for HIV using a third-generation enzyme-linked immunosorbent assay (EIA; Genetic Systems HIV1/2 Plus O EIA; Biorad Laboratories, Redmond, WA). Men who have sex with men with a negative HIV EIA result were tested using pooled HIV RNA testing. 9 
Statistical Analysis
The study sample includes only HIV-negative MSM and the unit of analysis is the clinic visit.
Comparison of Full Battery and Single Question
We compared the full battery of seroadaptive behaviors and the single question for 5 behaviors: (1) avoiding HIV-positive/ unknown-status partners, (2) using condoms with HIV-positive/ unknown-status partners, (3) having only insertive anal sex with HIV-positive/unknown-status partners, (4) having only oral sex or engaging in mutual masturbation (no anal sex) with HIVpositive/unknown-status partners, and (5) using condoms with all partners. This analysis was limited to men who had complete data for each behavior from both the full battery and single question. To directly compare the full battery and single question, we collapsed partnership-type data from the full battery (i.e., if a respondent engaged in a behavior with a main or casual partner, they were considered to have engaged in the behavior). For both the full battery and the single question, we combined behaviors with HIVpositive and unknown-status partners into single categories. For example, men who reported in the full questionnaire that they topped an HIV-positive and/or an unknown-status partner and who reported in the single question that they topped an HIV-positive partner and/or an unknown-status partner (i.e., they checked both boxes in the single question) would be in agreement for that specific behavior. We used Cohen κ statistic to measure the agreement between the 2 assessments and qualitatively classified agreement as slight (0.0-0.20), fair (0.21-0.40), moderate (0.41-0.60), substantial (0.61-0.80), and almost perfect (0.81-1.00). 10 
Prevalence and HIV Test Positivity of Behaviors Reported in Single Question
We present the prevalence of seroadaptive behaviors from the single question and the proportion of men testing newly HIV positive by behavior. We used Fisher exact test to compare the HIV test positivity of men who reported no seroadaptive behavior to men who reported at least one. We used chi-square tests for categorical variables and t tests for continuous variables to compare characteristics of men who reported no serodapative behaviors to men who reported at least one.
In additional analyses, we excluded from our analytic sample visits where men reported only 1 partner in the past 12 months, because those men may report different seroadaptive behaviors from men with at least 2 partners within 12 months. All analyses were completed using StataSE Version 13.0 (College Station, TX).
RESULTS
From February 2013 to June 2015, we enrolled HIVnegative MSM at 3341 (55%) of 6105 eligible visits, representing 1997 unique men. Of 3341 visits, 59 (1.8%) were by men who reported their HIV status as unknown. Approximately half of visits were by men who were younger than 30 years and nearly twothirds were by white, non-Hispanic men (Table 1) . At 91% of visits, men reported that they had at least 1 male sex partner in the past year. The percent of men testing newly HIV positive was 1.4%.
Comparison of Full Battery and Single Question
The prevalence of behaviors in the full battery versus the single question is presented in Table 2 . Based on κ values, the agreement between the full battery and single question was highest for consistent condom use (moderate agreement) and lowest for using condoms with HIV-positive/unknown-status partners (fair agreement).
Prevalence and HIV Test Positivity of Behaviors Reported in Single Question
Men provided data for the single question at 99.9% of visits (3336/3341). The median number of strategies reported in the past 12 months was 3 (interquartile range, 2-4), with 79.4% (2650/3336) reporting more than one strategy.
The most commonly endorsed strategy to reduce HIV risk was avoiding sex with HIV-positive men (Table 3) . Approximately half of respondents reported that they avoided sex with unknownstatus men or that they used condoms for anal sex with their unknown-status partners. At only 8% of visits, men reported that they did not engage in any of the behaviors to reduce their HIV risk.
The percent of men testing newly HIV positive (of behaviors that were asked during the entire study period) ranged from 0.3% for exclusively oral sex or mutual masturbation with HIVpositive partners to 1.3% for avoiding sex with unknown-status men (Table 3 ). There were no men who reporting ART/PrEPrelated behaviors who tested newly HIV positive, although the sample size for those categories was small. Men who reported no seroadaptive behavior had the highest risk of testing newly HIV positive (3.5%), which was a statistically significantly higher risk than men who reported at least one behavior (1.3%; P = 0.02).
Our additional analyses limiting the analytic sample to the 2888 visits where men reported at least 2 partners in the past 12 months did not differ appreciably from our primary findings.
Compared with men who reported at least one seroadaptive strategy (n = 3084), men who reported no seroadaptive strategy (n = 252) were slightly less likely to be white, non-Hispanic (59.1% vs 64.1%; P = 0.02) but were of similar age (mean age, 33.3 vs 34.0 years; P = 0.32). These men were significantly more likely to report methamphetamine use in the past 12 months (23.8% vs 10.0%; P < 0.001) and reported a slightly higher median number of sex partners (6 vs 5) compared with men who reported at least one seroadaptive behavior, but were similarly likely to be tested for HIV in the past year (80.0% vs 81.4%; P = 0.60).
DISCUSSION
In this clinic-based population of HIV-negative MSM, we found that our single seroadaptive behavior question performed relatively well against a longer and more comprehensive seroadaptive behaviors assessment. Results from the single question suggest that a variety of seroadaptive behaviors are common and that most men engage in several behaviors to reduce their risk of HIV. Although the HIV test positivity for the most commonly reported behaviors did not vary greatly (from 0.9% to 1.3%), the HIV test positivity was nearly 3 times higher (3.5%) for the subset of men who reported no seroadaptive behaviors in the past 12 months. These findings suggest that this single-question assessment is a reliable tool that could be used in a variety of settings to identify men at greatest risk for HIV.
The single question may be an appropriate replacement for larger seroadaptive behavior assessments in settings where the implementation of long behavioral surveys is not feasible. In our comparison of 5 seroadaptive behaviors, the prevalence of behaviors varied only somewhat between the full battery and single question and the agreement was fair to moderate, with κ values ranging from 0.34 to 0.59. Because of the absence of a goldstandard seroadaptive behaviors assessment, it is unclear whether the full battery or single question is more accurate, and thus, the motivation for implementing a seroadaptive behaviors assessment should drive which one is used. On the one hand, a full battery of seroadaptive behavior questions has the benefit of querying men about behaviors by partner type (main vs casual) and other partner characteristics (e.g., age, race, etc). Given that seroadaptive strategies may differ by partnership type, the collection of detailed partner data does have value. 11 On the other hand, collection of this detailed partner information is time consuming and may not be feasible or readily interpretable in some settings. In particular, in clinical settings, a single question may be easier for clinicians to use as a source of information relevant to gauging patient risk, counseling, and prioritizing PrEP. Therefore, longer and more detailed surveys should still be considered in settings where they are feasible and appropriate to implement. However, short assessments may be equally suitable in situations where brevity is paramount.
Considering that the HIV test positivity in our study population did not vary greatly for behaviors reported by more than a quarter of our study population (from 0.8% to 1.3%), it is striking that men who reported no seroadaptive behaviors in the past 12 months had an HIV test positivity that was 3 times higher than any other behavior. It is possible that these men used other HIV prevention strategies not listed in the single question or there were other factors that put these men at high risk for HIV. Notably, nearly one-quarter of these men reported methamphetamine use in the past year compared with 10% among men who reported at least one seroadaptive behavior. There are 2 important implications for this finding. First, this brief assessment could be used as a screening tool to identify men who are at greatest risk for HIV and may be ideal candidates for PrEP. Health jurisdictions working to develop local PrEP implementation guidelines may consider including (as a criterion) men who do not report any seroadaptive strategies. Second, at least in our population, engaging in any seroadaptive behavior is preferable to engaging in none. We believe that clinicians and others working in prevention should continue to emphasize that condoms are the best low-cost, broadly protective HIV prevention strategy for persons outside long-term, mutually monogamous relationships. However, for persons who do not consistently use condoms, a more flexible and often more realistic approach is to encourage men to adopt an HIV prevention strategy that includes any one of a number of behaviors.
Based on our findings, we recognize 2 opportunities where a brief seroadaptive behaviors assessment may be particularly useful. First, this tool can be used for sentinel behavioral surveillance. Data from the United States, Australia, and Canada suggest that partner viral load and PrEP use may impact sexual decision making among MSM, [12] [13] [14] but the trends in these behaviors have not been routinely monitored. Use of a brief behavioral assessment in the same population over time will help to understand what behaviors these newer ones (i.e., behaviors while on PrEP) are replacing and may also help explain changes in population-level HIV and STI rates. Second, brief seroadaptive behaviors assessments may be most valuable in geographically and racially diverse settings of MSM where estimates of the prevalence and protective effect of seroadaptive behaviors are limited. Black MSM and MSM residing in the Southern United States represent those at greatest risk for HIV infection 15, 16 but only a handful of studies have measured seroadaptive behaviors among black MSM, [17] [18] [19] [20] [21] most of which did not include black men residing in the South. Although racial disparities in HIV risk 22, 23 have not been attributed to individual risk behaviors, [24] [25] [26] [27] it is possible that black MSM in the South do not engage in seroadaptive behaviors at the same frequency as white MSM and/or that seroadaptive behaviors do not confer the same protective efficacy for black MSM as they do for white MSM. This may be true of serosorting, 17, 25 although it is unclear if this is the case for other seroadaptive behaviors or, if differences do exist, whether they factor into racial disparities in HIV incidence. The dearth of information on the topic motivates the use of an easily implementable behavioral assessment to explore this hypothesis.
This study has a number of strengths. We developed a short, easily modifiable, seroadaptive behaviors assessment that can be used in clinical and population-based settings. We enrolled a large sample of MSM to examine the question's reliability and to estimate the prevalence and protective effect of a variety of behaviors. There are also several important limitations. First, the single question appeared at the end of the full battery and it is possible that men were "primed" to answer it (i.e., after having been asked a series of seroadaptive behavior questions). It is unclear how our results would differ if the single question was asked first or in isolation of the full battery. Second, there is no gold-standard seroadaptive behavior measurement, so an examination of the validity of our single question is not possible. However, that persons reporting no seroadaptive behavior were at highest risk for HIVargues that our question had some validity. Third, these data are subject to recall bias because participants were asked about behaviors in the past year. However, the same recall period was used for both the full battery and single question so any potential recall bias would not likely have affected the agreement analysis, although it may have affected the prevalence estimates. Fourth, the absolute number of men who tested newly HIV positive was small, and thus, estimates of the proportion of men testing newly HIV positivity by behavior were often based on less than 10 events. Last, this was a population of clinic-based, predominately white, frequently *n/N = number testing HIV positive (n) of the number who tested for HIV (N). †Data for these 2 categories were only collected for 5 months (categories were added in February 2015).
